Central Nervous System Diseases

We are an academic contract research organisation (ACRO) devoted to executing clinical trials for CNS diseases in the most effective manner possible. We put science first, and it shows in every trial.

We approach every study with a mindset focused on solving clients’ challenges with tailored solutions and expertise specific to our CNS focus areas: Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), hearing loss (ENT), and epilepsy.

Meet our scientific leaders for trials

Prof. dr. Leonard van den Berg, neurologist at University Medical Centre (UMC) Utrecht and ALS Centrum. He is experienced in conducting global ALS trials, established the prominent TRICALS site network, and is chair of the European Network for the Cure of ALS.

Meet our scientific leaders for trials

Dr. Jort Vijverberg, a neurologist at the Brain Research Center and a senior researcher at Alzheimercentrum Amsterdam. He has been the principal investigator on many Alzheimer’s clinical trials and consults with the pharmaceutical industry.

Meet our scientific leaders for trials

Prof. dr. Anne Schilder, Ear Institute at University College London (UCL) senior investigator and leader of NIHR UCLH Biomedical Research Centre’s programme for translational hearing. She is a world leader in ENT research.

Meet our scientific leaders for trials

Dr. Cris Lanting, clinical physicist-audiologist, as well as a paediatric audiologist at Radboud University Medical Center (UMC).

Meet our scientific leaders for trials

Prof. dr. Eugen Trinka, chair of the neurology department at Paracelsus Medical University Salzburg and the Austrian Society of Neurology’s president-elect.

Highlighted trials

Brain Clinical is our proprietary network for CNS trials, providing experienced investigators and sites for CNS clinical trials.


The Brain Research Center is a specialised team of doctors, nurses, and neuropsychologists who are focused on client needs. They have extensive experience conducting clinical trials and have connections to innovative drug developers around the globe.

Read more

TRICALS, the largest European research initiative to find a cure for ALS, includes 48 top research centres in 16 countries. They are highly experienced in this area, providing efficient trial design and expert study oversight.

Read more

European Collaboration for Epilepsy Trials (ECET) is a group of expert scientists collaborating inside the Epilepsy Alliance Europe framework. They help provide access to epilepsy-focused centres and specialists.

Read more

We leverage our unique triangle of Science, Networks, and Operational excellence to run efficient trials across our CNS areas of expertise. A prime example is the SAPHIR study.

 

 

In the SAPHIR study, we helped the Sponsor fine-tune their protocol and identify specialised sites to overcome recruitment challenges. We ultimately helped them find 120 patients at 24 sites and streamline their project’s path to completion.


Our expert CNS team

Our operational team members average many years of experience running efficient central nervous system trials that deliver high- quality data for Julius Clinical’s Sponsors.

Lieza exalto
Maria papakrasa

Related webinars

The Alzheimer’s disease drug development landscape

Hosted by: Julius Clinical. Speakers: Pieter van Bokhoven | CSO| IAO Amsterdam Neuroscience AUMC Jort Vijverberg | Neurologist | Amsterdam Neuroscience AUMC Topics that are discussed during this webinar: All major trends in Alzh...

Speakers: Dr. Jort Vijverberg

CNS resources

Explore our CNS capabilities, studies, and other resources.

Download

"*" indicates required fields

*

Request for proposal

"*" indicates required fields

*
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn